mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.22 |
3e-10 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.21 |
3e-09 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.22 |
4e-09 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.21 |
5e-09 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.21 |
6e-09 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.21 |
1e-08 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
2e-08 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
7e-08 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
1e-07 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
3e-07 |